1. Home
  2. Labeler Index
  3. Hikma Pharmaceuticals Usa Inc.
  4. 0054-0399
  5. NDC Package Code: 0054-0399-25 Bexarotene

NDC Package 0054-0399-25 Bexarotene

Capsule, Liquid Filled Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0054-0399-25
Package Description:
100 CAPSULE, LIQUID FILLED in 1 BOTTLE
Product Code:
0054-0399
Proprietary Name:
Bexarotene
Non-Proprietary Name:
Bexarotene
Substance Name:
Bexarotene
Usage Information:
Bexarotene is used to treat skin problems from a certain type of cancer (cutaneous T-cell lymphoma-CTCL). It belongs to a class of drugs called retinoids (vitamin A derivatives). Bexarotene works by slowing or stopping the growth of cells.
11-Digit NDC Billing Format:
00054039925
NDC to RxNorm Crosswalk:
  • RxCUI: 308725 - bexarotene 75 MG Oral Capsule
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Hikma Pharmaceuticals Usa Inc.
    Dosage Form:
    Capsule, Liquid Filled - A solid dosage form in which the drug is enclosed within a soluble, gelatin shell which is plasticized by the addition of a polyol, such as sorbitol or glycerin, and is therefore of a somewhat thicker consistency than that of a hard shell capsule; typically, the active ingredients are dissolved or suspended in a liquid vehicle.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
    • Active Ingredient(s):
  • BEXAROTENE 75 mg/1
    • Pharmacologic Class(es):
  • Retinoid - [EPC] (Established Pharmacologic Class)
  • Retinoids - [CS]
    • Sample Package:
    No
    FDA Application Number:
    ANDA203663
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    11-11-2020
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0054-0399-25?

    The NDC Packaged Code 0054-0399-25 is assigned to a package of 100 capsule, liquid filled in 1 bottle of Bexarotene, a human prescription drug labeled by Hikma Pharmaceuticals Usa Inc.. The product's dosage form is capsule, liquid filled and is administered via oral form.

    Is NDC 0054-0399 included in the NDC Directory?

    Yes, Bexarotene with product code 0054-0399 is active and included in the NDC Directory. The product was first marketed by Hikma Pharmaceuticals Usa Inc. on November 11, 2020 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 0054-0399-25?

    The 11-digit format is 00054039925. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20054-0399-255-4-200054-0399-25